NCT00538720View on ClinicalTrials.gov

Effects of Vitamin D Replacement in Patients With Primary Hyperparathyroidism (PHPT)

PHASE1CompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

October 31, 2007

Primary Completion Date

May 30, 2018

Study Completion Date

May 30, 2018

Conditions
Hyperparathyroidism
Interventions
DRUG

Vitamin D

Starting dose 50,000 IU by mouth 3 times weekly for three weeks (+/- one week), then 50,000 IU twice weekly for 6 weeks (+/- one week).

DEVICE

Four-dimensional computed tomography (4DCT)

Four-dimensional computed tomography (4DCT) scan of the neck.

Trial Locations (1)

77030

University of Texas MD Anderson Cancer Center, Houston

All Listed Sponsors
lead

M.D. Anderson Cancer Center

OTHER

NCT00538720 - Effects of Vitamin D Replacement in Patients With Primary Hyperparathyroidism (PHPT) | Biotech Hunter | Biotech Hunter